Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. 2010

Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
Charité-Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Berlin, Germany. katja.wiethoff@charite.de

OBJECTIVE The objective of this study was to explore the prevalence of anxious depression in an inpatient population, to describe its clinical and sociodemographic correlates, and to compare treatment outcomes between patients with anxious and nonanxious depression. Furthermore, the efficacy of algorithm-guided treatment versus treatment as usual in patients with anxious versus nonanxious depression was evaluated. METHODS Data were collected on 429 inpatients with the diagnosis of a depressive episode (according to ICD-10) and a score of ≥ or = 15 on the 21-item Hamilton Depression Rating Scale (HDRS-21). The German Algorithm Project, phase 3 (GAP3), was conducted between 2000 and 2005 in 10 psychiatric departments throughout Germany. A baseline HDRS-21 anxiety/somatization factor score of ≥ or = 7 was considered indicative of anxious depression. Remission was defined as an HDRS-21 score or ≤ = 9. To evaluate the efficacy of algorithm-guided treatment, patients were randomly assigned into 3 groups: 2 different treatment algorithms or treatment as usual. RESULTS The prevalence of anxious depression was 49%. Patients with anxious depression were more likely than those with nonanxious depression to be older (mean ± SD = 45.3 ± 12.8 vs 42.9 ± 12.0 years, odds ratio [OR] = 1.02 [95% CI, 1.00-1.03], P = .046), retired (70% vs 30%, OR = 3.09 [95% CI, 1.70-5.62], P = .000), without school qualification (74% vs 26%, OR = 3.11 [95% CI, 1.09-8.83], P = .035), more severely depressed (mean ± SD HDRS-21 score = 20.1 ± 5.0 vs 18.5 ± 4.4, OR = 1.08 [95% CI, 1.03-1.12], P = .001), and more likely to have a longer duration of the current episode (mean ± SD = 20.9 ± 26.2 vs 13.7 ± 14.3 weeks, OR = 1.02 [95% CI, 1.01-1.03], P = .011). Patients with anxious depression were more likely to display a variety of melancholic features. In patients with anxious depression compared to those with nonanxious depression, remission was less likely to be achieved (48.6% vs 61.5%, OR = 0.63 [95% CI, 0.42-0.92], P = .018) and took longer to occur (mean ± SD = 44 ± 3.4 vs 30 ± 2.8 days, HR = 0.65 [95% CI, 0.50-0.85], P = .001). There was no significant interaction with the treatment mode with regard to remission (Wald = 0.20, P = .890). CONCLUSIONS Anxious depression is common in patients diagnosed with depression. The poorer treatment outcome in patients with anxious depression demonstrates the need to address the issue of specific treatment strategies for this subgroup. However, anxious depression has no moderating effect on the efficacy of algorithm-guided treatment. BACKGROUND http://www.germanctr.de/ Identifier: DRKS00000161.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010555 Personality Inventory Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. Edwards Personal Preference Schedule,Myers-Briggs Type Indicator,Indicator, Myers-Briggs Type,Inventories, Personality,Inventory, Personality,Myers Briggs Type Indicator,Personality Inventories
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003865 Depressive Disorder, Major Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5) Depression, Involutional,Major Depressive Disorder,Melancholia, Involutional,Paraphrenia, Involutional,Psychosis, Involutional,Depressive Disorders, Major,Involutional Depression,Involutional Melancholia,Involutional Paraphrenia,Involutional Paraphrenias,Involutional Psychoses,Involutional Psychosis,Major Depressive Disorders,Paraphrenias, Involutional,Psychoses, Involutional
D005260 Female Females
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
August 1993, The American journal of psychiatry,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
March 2008, The American journal of psychiatry,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
March 2019, Depression and anxiety,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
April 2010, Journal of psychopharmacology (Oxford, England),
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
September 2022, Journal of affective disorders,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
January 2012, Psychotherapy and psychosomatics,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
October 2016, Comprehensive psychiatry,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
September 2013, Journal of affective disorders,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
December 2014, Psychiatry research,
Katja Wiethoff, and Michael Bauer, and Thomas C Baghai, and Hans-Jürgen Möller, and Robert Fisher, and Dorothea Hollinde, and Julia Kiermeir, and Iris Hauth, and Gerd Laux, and Joachim Cordes, and Peter Brieger, and Klaus-Thomas Kronmüller, and Joachim Zeiler, and Mazda Adli
December 2019, Journal of affective disorders,
Copied contents to your clipboard!